Enhanced diagnosis of severe bacterial and fungal respiratory infection in children using a rapid syndromic array-case report
Related Experiment Video
Updated: Jun 9, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
John Alexander Clark1,2, Theodore Gouliouris2,3, Andrew Conway Morris2,4,5
1Department of Paediatrics, Addenbrooke's Hospital, Cambridge Biomedical Campus, Cambridge, UK.
Background:
A microbiological cause of infection is infrequently identified in critically unwell children with a respiratory infection. Molecular diagnostic arrays provide an alternative. These tests are becoming more broadly available, but little is known about how clinicians interpret the results to impact clinical decision making.
Case Description:
Here we describe three cases of bacterial and fungal lower respiratory tract infection (LRTI) diagnosed in the paediatric intensive care unit (PICU) using a custom 52 respiratory pathogen TaqMan array card (TAC). Firstly, an early diagnosis of Candida albicans pneumonia was made with the support of the TAC in a trauma patient who received prolonged mechanical ventilation. The pathogen was only identified on microbiological cultures after further clinical deterioration had occurred. Secondly, a rare case of psittacosis was identified in an adolescent with acute respiratory distress, initially suspected to have multisystem inflammatory syndrome in children (MIS-C). Finally, Haemophilus influenzae pneumonia was identified in an infant with recurrent apnoeas, initially treated for meningitis. Two diagnoses would not have been established using commercially available arrays, and pathogen-specific diagnoses were established faster than that of routine microbiological culture.
Conclusions:
The pathogens included on molecular arrays and interpretation by a multidisciplinary team are crucial in providing value to PICU diagnostic services. Molecular arrays have the potential to enhance early pathogen-specific diagnosis of LRTI in the PICU.
Insights
Molecular diagnostic arrays rapidly identify bacterial and fungal pathogens in critically ill children with respiratory infections. These advanced tests aid early, specific diagnoses in the pediatric intensive care unit (PICU).
Area of Science:
- Microbiology
- Molecular Diagnostics
- Pediatric Critical Care
Background:
- Identifying the microbiological cause of severe respiratory infections in critically ill children is challenging.
- Molecular diagnostic arrays offer a promising alternative for pathogen detection.
- Understanding clinician interpretation of these array results for decision-making is limited.
Observation:
- A custom 52-respiratory pathogen TaqMan array card (TAC) was used to diagnose three cases of bacterial and fungal lower respiratory tract infection (LRTI) in a pediatric intensive care unit (PICU).
- Early diagnosis of *Candida albicans* pneumonia in a ventilated trauma patient was supported by TAC, preceding culture results.
- A rare case of psittacosis and *Haemophilus influenzae* pneumonia were also identified, with diagnoses faster than conventional methods.
Findings:
- The custom TAC enabled diagnoses not achievable with commercially available arrays.
- Pathogen-specific diagnoses were established more rapidly compared to routine microbiological cultures.
- Two of the three cases involved rare pathogens or atypical presentations.
Implications:
- The selection of pathogens on molecular arrays and multidisciplinary interpretation are key for effective PICU diagnostics.
- Molecular arrays hold significant potential for improving early, pathogen-specific diagnosis of LRTI in the PICU.
- These findings support the broader integration of molecular diagnostics in pediatric critical care settings.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
Rapid Identification of Pathogens
Automated Microbial Diagnostics
Respiratory Syncytial Virus Disease

